Basic research for the development of peptide vaccine targeting URLC10, KOC1 and CDCA1

Basic research for the development of peptide vaccine targeting URLC10, KOC1 and CDCA1 - Basic research for the development of peptide vaccine targeting URLC10, KOC1 and CDCA1

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000004756

Enrollment

Registered

2011-01-04

Start date

2012-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The head and neck squamous cell carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The histopathologically diagnosed head and neck squmous cell carcinoma patients

Exclusion criteria

Exclusion criteria: Patients unconsenting to the proposal Patients incapable of making his/her intention

Design outcomes

Primary

Measure	Time frame
Expression levels of URLC10, CDCA1, KOC1 and p16 in both carcinoma and normal control tissue Genotype of HLA-A Expression level of HLA class I molecule in carcinoma tissue	—

Countries

Japan

Contacts

Public ContactHideaki Takahashi

Yokohama City University Hospital Department of Otolaryngology

t096036d@yokohama-cu.ac.jp045-787-2687

Outcome results